INMB250919P00012500 Option on INmune Bio
INMB Stock | USD 2.36 0.06 2.48% |
INMB250919P00012500 is a PUT option contract on INmune Bio's common stock with a strick price of 12.5 expiring on 2025-09-19. The contract was not traded in recent days and, as of today, has 60 days remaining before the expiration. The option is currently trading at a bid price of $9.7, and an ask price of $10.5. The implied volatility as of the 21st of July is 60.0.
A put option written on INmune Bio becomes more valuable as the price of INmune Bio drops. Conversely, INmune Bio's put option loses its value as INmune Stock rises.
Rule 16 of 2025-09-19 Option Contract
The options market is anticipating that INmune Bio will have an average daily up or down price movement of about 0.13% per day over the life of the option. With INmune Bio trading at USD 2.36, that is roughly USD 0.003168. If you think that the market is fully understating INmune Bio's daily price movement you should consider buying INmune Bio options at that current volatility level of 2.15%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
In The Money Put Option on INmune Bio
An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their INmune Bio positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on INmune Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
Put Contract Name | INMB250919P00012500 |
Expires On | 2025-09-19 |
Days Before Expriration | 60 |
Vega | 0.00113 |
Gamma | 0.058015 |
Theoretical Value | 10.1 |
Open Interest | 327 |
Strike Price | 12.5 |
Last Traded At | 10.55 |
Current Price Spread | 9.7 | 10.5 |
Rule 16 Daily Up or Down | USD 0.003168 |
INmune short PUT Option Greeks
INmune Bio's Option Greeks for the contract ending on 2025-09-19 at a strike price of 12.5 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to INmune Bio's option greeks, its implied volatility helps estimate the risk of INmune Bio stock implied by the prices of the options on INmune Bio's stock.
Delta | -0.940212 | |
Gamma | 0.058015 | |
Theta | -0.00156 | |
Vega | 0.00113 | |
Rho | -0.005637 |
INmune long PUT Option Payoff at expiration
Put options written on INmune Bio grant holders of the option the right to sell a specified amount of INmune Bio at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of INmune Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on INmune Bio is like buying insurance aginst INmune Bio's downside shift.
Profit |
INmune Bio Price At Expiration |
INmune short PUT Option Payoff at expiration
By selling INmune Bio's put option, the investors signal their bearish sentiment. A short position in a put option written on INmune Bio will generally make money when the underlying price is above the strike price. Therefore INmune Bio's put payoff at expiration depends on where the INmune Stock price is relative to the put option strike price. The breakeven price of 2.4 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to INmune Bio's price. Finally, at the strike price of 12.5, the payoff chart is constant and positive.
Profit |
INmune Bio Price At Expiration |
INmune Bio Available Put Options
INmune Bio's option chain is a display of a range of information that helps investors for ways to trade options on INmune. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for INmune. It also shows strike prices and maturity days for a INmune Bio against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open Int | Strike Price | Current Spread | Last Price | |||
Put | INMB250919P00022500 | 0 | 22.5 | 19.5 - 20.8 | 19.5 | In |
Put | INMB250919P00020000 | 422 | 20.0 | 17.2 - 18.8 | 17.97 | In |
Put | INMB250919P00017500 | 90 | 17.5 | 14.1 - 16.3 | 15.5 | In |
Put | INMB250919P00015000 | 52 | 15.0 | 11.6 - 13.1 | 12.8 | In |
Put | INMB250919P00012500 | 327 | 12.5 | 9.7 - 10.5 | 10.55 | In |
Put | INMB250919P00010000 | 980 | 10.0 | 6.4 - 7.9 | 7.8 | In |
Put | INMB250919P00007500 | 2932 | 7.5 | 5.0 - 5.4 | 5.15 | In |
Put | INMB250919P00006000 | 160 | 6.0 | 2.8 - 4.0 | 3.95 | In |
Put | INMB250919P00005000 | 1035 | 5.0 | 2.55 - 2.9 | 2.79 | In |
Put | INMB250919P00004000 | 3241 | 4.0 | 1.5 - 2.8 | 1.9 | In |
Put | INMB250919P00002500 | 2425 | 2.5 | 0.5 - 0.6 | 0.57 | In |
Put | INMB250919P00001000 | 249 | 1.0 | 0.05 - 0.1 | 0.05 | Out |
INmune Bio Corporate Management
Christopher Barnum | Head Neuroscience | Profile | |
BSc FRCPath | Chief Officer | Profile | |
Mark Lowdell | Chief Officer | Profile | |
Raymond MD | President, CoFounder | Profile | |
Joshua Esq | General Counsel | Profile | |
David MBA | Treasurer CFO | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in INmune Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade INmune Stock refer to our How to Trade INmune Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INmune Bio. If investors know INmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.93) | Revenue Per Share | Quarterly Revenue Growth 2.571 | Return On Assets | Return On Equity |
The market value of INmune Bio is measured differently than its book value, which is the value of INmune that is recorded on the company's balance sheet. Investors also form their own opinion of INmune Bio's value that differs from its market value or its book value, called intrinsic value, which is INmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INmune Bio's market value can be influenced by many factors that don't directly affect INmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if INmune Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.